Repeated reserpine administration up-regulates the transduction mechanisms of D1 receptors without changing the density of [3H]SCH 23390 binding

Brain Res. 1989 Mar 27;483(1):117-22. doi: 10.1016/0006-8993(89)90041-3.


Behavioural studies have shown that stimulation of D1 receptors, which is uneffective in normal rats, induced strong hypermotility in rats pretreated with reserpine for 5 days. On this basis, we investigated D1 receptor plasticity using the 5-day treatment with reserpine (1 mg/kg; s.c.) as an experimental model. The function of striatal D1 receptors was determined both in binding studies with [3H]SCH 23390 and by measuring formation of cAMP in response to the selective agonist, SKF 82526. The results indicate that the responsiveness of adenylate cyclase (AC) to D1 receptor stimulation was markedly increased after reserpine administration, while no significant changes were found in [3H]SCH 23390 binding site density. Moreover, formation of cAMP after stimulation of Gs protein with GppNHp was markedly enhanced in dopamine (DA)-depleted rats; the responsiveness of AC to forskolin, which directly stimulates the AC catalytic unit, was not affected by reserpine administration. These data indicate that reserpine-induced D1 receptor up-regulation is apparently mediated by a marked enhancement of the coupling efficiency of Gs protein, suggesting that the D1 behavioral supersensitivity does not correlate with the density of D1 receptors, but is reflected by a selective up-regulation of their transduction mechanisms.

MeSH terms

  • Adenylyl Cyclases / metabolism
  • Animals
  • Benzazepines / metabolism*
  • Benzazepines / pharmacology
  • Corpus Striatum / drug effects
  • Corpus Striatum / metabolism*
  • Corpus Striatum / physiology
  • Cyclic AMP / metabolism*
  • Fenoldopam
  • Male
  • Motor Activity / drug effects*
  • Rats
  • Rats, Inbred Strains
  • Receptors, Dopamine / drug effects*
  • Receptors, Dopamine / physiology
  • Receptors, Dopamine D1
  • Reserpine / administration & dosage*
  • Signal Transduction / drug effects*


  • Benzazepines
  • Receptors, Dopamine
  • Receptors, Dopamine D1
  • Reserpine
  • Cyclic AMP
  • Adenylyl Cyclases
  • Fenoldopam